Loss of the expression of DNMT1 causes hypomethylation of the whole genome.31 This correlation of PARP1 with methylation is very important, since hypermethylation is a major event in the pathogenesis of MDS, and hypomethylating agents are the most effective available treatment option in patients with MDS. The gene discussed is PARP1; the disease is myelodysplastic syndrome.